Disrupted GABAergic facilitation of working memory performance in people with schizophrenia

J. D. Ragland, R. J. Maddock, M. Y. Hurtado, C. Tanase, T. A. Lesh, T. A. Niendam, C. S. Carter, C. Ranganath

Research output: Contribution to journalArticle

Abstract

Objectives: Gamma-Amiobutyric acid (GABA) is a primary inhibitory neurotransmitter that facilitates neural oscillations that coordinate neural activity between brain networks to facilitate cognition. The present magnetic resonance spectroscopy (MRS) study tests the hypothesis that GABAergic facilitation of working memory is disrupted in people with schizophrenia (PSZ). Methods: 51 healthy participants and 40 PSZ from the UC Davis Early Psychosis Program performed an item and temporal order working memory (WM) task and underwent resting MRS to measure GABA and glutamate concentrations in dorsolateral prefrontal (DLPFC) and anterior cingulate (ACC) regions of interest. MRS was acquired on a 3 Tesla Siemens scanner and GABA and glutamate concentrations were referenced to creatine. Percent correct on the WM task indexed performance and correlation coefficients examined GABAergic or Glutamatergic facilitation of WM, with Fisher's Z transformation testing for group differences. Results: There were no group differences in GABA or glutamate concentrations, but WM correlations were reversed between groups. In patients, higher DLPFC GABA was associated with worse rather than better WM performance. This pattern was not observed for glutamate or in the ACC. Although under-powered, there was no indication of medication effects. Conclusions and Relevance: Results cannot be explained by group differences in DLPFC GABA or glutamate concentrations but, instead, indicate that schizophrenia disrupts the GABAergic facilitation of WM seen in healthy individuals. Results appear to parallel post mortem findings in suggesting that schizophrenia alters the distribution of different classes of GABAergic interneurons rather than producing a general deficit across the total population of neurons.

Original languageEnglish (US)
Article number102127
JournalNeuroImage: Clinical
Volume25
DOIs
StatePublished - 2020

Fingerprint

Short-Term Memory
Schizophrenia
Glutamic Acid
Acids
Magnetic Resonance Spectroscopy
Gyrus Cinguli
Creatine
Task Performance and Analysis
Interneurons
Psychotic Disorders
Cognition
Neurotransmitter Agents
Healthy Volunteers
Neurons
Brain
Population

Keywords

  • Functional neuroimaging
  • Gamma-aminobutyric acid (GABA)
  • Magnetic resonance spectroscopy (MRS)
  • Psychosis
  • Working memory

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Neurology
  • Clinical Neurology
  • Cognitive Neuroscience

Cite this

Disrupted GABAergic facilitation of working memory performance in people with schizophrenia. / Ragland, J. D.; Maddock, R. J.; Hurtado, M. Y.; Tanase, C.; Lesh, T. A.; Niendam, T. A.; Carter, C. S.; Ranganath, C.

In: NeuroImage: Clinical, Vol. 25, 102127, 2020.

Research output: Contribution to journalArticle

@article{ea1a7427c8ec4d9e9c3a1c6f2090fb7b,
title = "Disrupted GABAergic facilitation of working memory performance in people with schizophrenia",
abstract = "Objectives: Gamma-Amiobutyric acid (GABA) is a primary inhibitory neurotransmitter that facilitates neural oscillations that coordinate neural activity between brain networks to facilitate cognition. The present magnetic resonance spectroscopy (MRS) study tests the hypothesis that GABAergic facilitation of working memory is disrupted in people with schizophrenia (PSZ). Methods: 51 healthy participants and 40 PSZ from the UC Davis Early Psychosis Program performed an item and temporal order working memory (WM) task and underwent resting MRS to measure GABA and glutamate concentrations in dorsolateral prefrontal (DLPFC) and anterior cingulate (ACC) regions of interest. MRS was acquired on a 3 Tesla Siemens scanner and GABA and glutamate concentrations were referenced to creatine. Percent correct on the WM task indexed performance and correlation coefficients examined GABAergic or Glutamatergic facilitation of WM, with Fisher's Z transformation testing for group differences. Results: There were no group differences in GABA or glutamate concentrations, but WM correlations were reversed between groups. In patients, higher DLPFC GABA was associated with worse rather than better WM performance. This pattern was not observed for glutamate or in the ACC. Although under-powered, there was no indication of medication effects. Conclusions and Relevance: Results cannot be explained by group differences in DLPFC GABA or glutamate concentrations but, instead, indicate that schizophrenia disrupts the GABAergic facilitation of WM seen in healthy individuals. Results appear to parallel post mortem findings in suggesting that schizophrenia alters the distribution of different classes of GABAergic interneurons rather than producing a general deficit across the total population of neurons.",
keywords = "Functional neuroimaging, Gamma-aminobutyric acid (GABA), Magnetic resonance spectroscopy (MRS), Psychosis, Working memory",
author = "Ragland, {J. D.} and Maddock, {R. J.} and Hurtado, {M. Y.} and C. Tanase and Lesh, {T. A.} and Niendam, {T. A.} and Carter, {C. S.} and C. Ranganath",
year = "2020",
doi = "10.1016/j.nicl.2019.102127",
language = "English (US)",
volume = "25",
journal = "NeuroImage: Clinical",
issn = "2213-1582",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Disrupted GABAergic facilitation of working memory performance in people with schizophrenia

AU - Ragland, J. D.

AU - Maddock, R. J.

AU - Hurtado, M. Y.

AU - Tanase, C.

AU - Lesh, T. A.

AU - Niendam, T. A.

AU - Carter, C. S.

AU - Ranganath, C.

PY - 2020

Y1 - 2020

N2 - Objectives: Gamma-Amiobutyric acid (GABA) is a primary inhibitory neurotransmitter that facilitates neural oscillations that coordinate neural activity between brain networks to facilitate cognition. The present magnetic resonance spectroscopy (MRS) study tests the hypothesis that GABAergic facilitation of working memory is disrupted in people with schizophrenia (PSZ). Methods: 51 healthy participants and 40 PSZ from the UC Davis Early Psychosis Program performed an item and temporal order working memory (WM) task and underwent resting MRS to measure GABA and glutamate concentrations in dorsolateral prefrontal (DLPFC) and anterior cingulate (ACC) regions of interest. MRS was acquired on a 3 Tesla Siemens scanner and GABA and glutamate concentrations were referenced to creatine. Percent correct on the WM task indexed performance and correlation coefficients examined GABAergic or Glutamatergic facilitation of WM, with Fisher's Z transformation testing for group differences. Results: There were no group differences in GABA or glutamate concentrations, but WM correlations were reversed between groups. In patients, higher DLPFC GABA was associated with worse rather than better WM performance. This pattern was not observed for glutamate or in the ACC. Although under-powered, there was no indication of medication effects. Conclusions and Relevance: Results cannot be explained by group differences in DLPFC GABA or glutamate concentrations but, instead, indicate that schizophrenia disrupts the GABAergic facilitation of WM seen in healthy individuals. Results appear to parallel post mortem findings in suggesting that schizophrenia alters the distribution of different classes of GABAergic interneurons rather than producing a general deficit across the total population of neurons.

AB - Objectives: Gamma-Amiobutyric acid (GABA) is a primary inhibitory neurotransmitter that facilitates neural oscillations that coordinate neural activity between brain networks to facilitate cognition. The present magnetic resonance spectroscopy (MRS) study tests the hypothesis that GABAergic facilitation of working memory is disrupted in people with schizophrenia (PSZ). Methods: 51 healthy participants and 40 PSZ from the UC Davis Early Psychosis Program performed an item and temporal order working memory (WM) task and underwent resting MRS to measure GABA and glutamate concentrations in dorsolateral prefrontal (DLPFC) and anterior cingulate (ACC) regions of interest. MRS was acquired on a 3 Tesla Siemens scanner and GABA and glutamate concentrations were referenced to creatine. Percent correct on the WM task indexed performance and correlation coefficients examined GABAergic or Glutamatergic facilitation of WM, with Fisher's Z transformation testing for group differences. Results: There were no group differences in GABA or glutamate concentrations, but WM correlations were reversed between groups. In patients, higher DLPFC GABA was associated with worse rather than better WM performance. This pattern was not observed for glutamate or in the ACC. Although under-powered, there was no indication of medication effects. Conclusions and Relevance: Results cannot be explained by group differences in DLPFC GABA or glutamate concentrations but, instead, indicate that schizophrenia disrupts the GABAergic facilitation of WM seen in healthy individuals. Results appear to parallel post mortem findings in suggesting that schizophrenia alters the distribution of different classes of GABAergic interneurons rather than producing a general deficit across the total population of neurons.

KW - Functional neuroimaging

KW - Gamma-aminobutyric acid (GABA)

KW - Magnetic resonance spectroscopy (MRS)

KW - Psychosis

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=85076454078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076454078&partnerID=8YFLogxK

U2 - 10.1016/j.nicl.2019.102127

DO - 10.1016/j.nicl.2019.102127

M3 - Article

AN - SCOPUS:85076454078

VL - 25

JO - NeuroImage: Clinical

JF - NeuroImage: Clinical

SN - 2213-1582

M1 - 102127

ER -